Positive EMA Opinions Could Bode Well For US Approvals of Biosimilars
September 7, 2016
Stacie Ropka, PhD
The Pharma Letter
Axinn counsel Stacie Ropka co-authored the article, "Positive EMA Opinions Could Bode Well For US Approvals of Biosimilars," for The Pharma Letter.
Click here to access the article. A subscription is required.